Nomura et al. reported that aggressive cancer lines of various cellular lineages and primary ovarian carcinomas and melanomas may hijack overexpressed MGLL to drive tumorigenesis by remodeling fatty acids to yield a signaling network enriched with pro-oncogenic lipid metabolites such as lipophosphatidic acid and prostaglandins [14]. The gene discussed is MGLL; the disease is cancer.